$50 for your first 3 months Get the print edition and steer from crisis to recovery
Add this topic to your myFT Digest for news straight to your inbox
Move highlights EU’s mounting problems with coronavirus vaccine rollout
Contract with drugmaker entitles bloc to production from its British facilities, say officials
Lack of access to jabs in emerging markets could have global consequences, fund says
Abingdon Health omits UK health department’s move from trading update
Findings will play big role in determining how quickly lockdown is lifted, officials say
Rollout of Covid jabs has brought vaccine nationalism back on to the agenda
Israel’s leader sees long race ahead between Covid vaccinations and mutations
Worries grow in bloc over supply shortfalls and rollout in member states
New technologies can bring benefits both to the poorest parts of the planet and to investors
Roz Brewer will become only black woman to run an S&P 500 company
Covid-19 inoculation campaign delayed by Tokyo’s demand for Japan-specific data
Despite Bolsonaro’s support, AstraZeneca says it does not currently sell jabs to private sector
Pharmaceutical industry faces new race as worrying variants emerge
Mounting pressure over sluggish start to vaccinations and shortages of doses
More transparency on pharmaceutical deals is needed but an export ban is not
Health ministry suggests media muddled statistics in concluding efficacy rates were as low as 8% in over 65s
Indian PM’s reluctance to offer a vaccination photo-opportunity fuels speculation over his motive
Phase 3 trial data for its candidate due to be released early next week
London university ditches plans for efficacy trial to focus on developing next-generation jabs
Fund predicts that Europe and emerging markets will be lagging behind in 2022
After a year of breakneck research and development, inoculations have begun
Botched cull of up to 17m animals over fears of virus mutation sparked anger against government
Officials in Tonghua battle rare public outcry over late deliveries of daily necessities
Covid will be around for a long time — virus suppression is the right policy
International Edition
